- Home
- DXYZ vs IRMD Comparison
DXYZ vs IRMD Comparison
Compare DXYZ & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DXYZ | IRMD |
|---|---|---|
| Founded | N/A | 1992 |
| Country | | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 563.5M | 1.3B |
| IPO Year | 2024 | 2014 |
Fundamental Metrics
Financial Performance| Metric | DXYZ | IRMD |
|---|---|---|
| Price | $24.27 | $99.28 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 586.7K | 49.5K |
| Earning Date | N/A | 05-04-2026 |
| Dividend Yield | N/A | ★ 0.80% |
| EPS Growth | N/A | ★ 16.67 |
| EPS | N/A | ★ 1.75 |
| Revenue | N/A | ★ $83,814,000.00 |
| Revenue This Year | N/A | $11.99 |
| Revenue Next Year | N/A | $9.91 |
| P/E Ratio | ★ N/A | $56.82 |
| Revenue Growth | N/A | ★ 14.43 |
| 52 Week Low | $19.71 | $47.48 |
| 52 Week High | $50.50 | $107.90 |
Technical Indicators
Market Signals| Indicator | DXYZ | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 33.18 | 47.08 |
| Support Level | $23.35 | $97.37 |
| Resistance Level | $28.23 | $106.61 |
| Average True Range (ATR) | 0.83 | 2.93 |
| MACD | -0.14 | -0.27 |
| Stochastic Oscillator | 9.91 | 23.21 |
Price Performance
Historical ComparisonAbout DXYZ Destiny Tech100 Inc.
Destiny Tech100 Inc is a non-diversified, closed-end management investment company. It is designed to be an investment portfolio of the Top 100 High-Growth Tech Companies.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.